NEKTAR THERAPEUTICS (15) | Collaboration Agreements (2)
- Amendment No. 2 to Strategic Collaboration Agreement dated as of January 12, 2022, by and between Bristol-M (Filed With SEC on March 1, 2022)
- Amendment No. 1 to Strategic Collaboration Agreement dated as of January 9, 2020, by and between Bristol-Myers Squibb and Company and Nektar Therapeutics (Filed With SEC on February 28, 2020)
